Schizophrenia Disorder Clinical Trials

30 recruitingLast updated: July 25, 2026

There are 30 actively recruiting schizophrenia disorder clinical trials across 12 countries. Studies span Not Applicable, Phase 1, Phase 2, Phase 3. Top locations include Beijing, Beijing Municipality, China, Aarhus, Denmark, Balkbrug, Overijssel, Netherlands. Updated daily from ClinicalTrials.gov.


Schizophrenia Disorder Trials at a Glance

30 actively recruiting trials for schizophrenia disorder are listed on ClinicalTrialsFinder across 6 cities in 12 countries. The largest study group is Not Applicable with 20 trials, with the heaviest enrollment activity in Beijing, Aarhus, and Balkbrug. Lead sponsors running schizophrenia disorder studies include Anders Fink-Jensen, MD, DMSci, Beykoz University, and Akrivia Health.

Browse schizophrenia disorder trials by phase

Treatments under study

About Schizophrenia Disorder Clinical Trials

Looking for clinical trials for Schizophrenia Disorder? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Schizophrenia Disorder trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Schizophrenia Disorder clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 30 trials

Recruiting
Phase 3

Cognitive Strategies in Early Psychosis 2

Major Depressive Disorder with Psychotic featuresCognitionPsychosis+6 more
University of Minnesota24 enrolled1 locationNCT07263022
Recruiting
Not Applicable

TIS for Improving Cognitive Impairment in Schizophrenia

Cognitive ImpairmentsSchizophrenia Disorder
Central South University50 enrolled1 locationNCT07647380
Recruiting

Transition Care for FEP

Major Depressive Disorder with Psychotic featuresschizoaffective disordersSchizophrenia Disorders+2 more
University of Chicago75 enrolled2 locationsNCT07713849
Recruiting
Not Applicable

MicroRNAs as Biomarkers in First Episode Schizophrenia

Schizoaffective DisorderSchizophreniform DisorderSchizophrenia Disorder+1 more
Northwell Health160 enrolled1 locationNCT07703670
Recruiting

Medical Phenotyping of NHS General Adult Psychiatry (GAP) Inpatients

Schizophrenia DisordersPersonality DisordersDepression Disorders+1 more
University of Edinburgh100 enrolled1 locationNCT07398365
Recruiting
Phase 1

The Purpose of This Study is to Determine the Safety, Tolerability, and Pharmacokinetics of Brexpiprazole Long-acting Injection Following a Single Administration in Healthy Subjects/Patients With Schizophrenia.

Schizophrenia Disorders
Sichuan Kelun Pharmaceutical Co.,Ltd.56 enrolled1 locationNCT06674694
Recruiting
Not Applicable

SEEG-Guided DBS for Schizophrenia

Schizophrenia DisordersSchizo Affective Disorder
Ruijin Hospital46 enrolled1 locationNCT07671261
Recruiting
Not Applicable

A Virtual Reality Mindfulness Application for Aggression in Schizophrenia

AggressionSchizophrenia DisorderSchizoaffecitve Disorder
Manhattan Psychiatric Center58 enrolled2 locationsNCT07434479
Recruiting
Not Applicable

Cognitive Remediation Method Using Rhythmic, Vocal and Corporal Musical Learning for Schizophrenia

Schizophrenia Disorders
University Hospital, Toulouse120 enrolled6 locationsNCT07055204
Recruiting
Not Applicable

Volatility in Paranoia (VIP) Trial: An RCT of Changes in Volatility With Psychotherapy

Schizophrenia Disorders
Vanderbilt University Medical Center120 enrolled1 locationNCT06835556
Recruiting
Not Applicable

The Key to Integrated Trauma Treatment in Psychosis Trial

Schizophrenia DisordersPsychiatric DiagnosisPsychological Trauma, Historical
Haukeland University Hospital187 enrolled11 locationsNCT06608706
Recruiting
Not Applicable

Brain Stimulation to the Hippocampus in Schizophrenia

Schizophrenia DisordersMental DisorderPsychotic Disorder
Stanford University60 enrolled1 locationNCT07010614
Recruiting
Not Applicable

White Matter Plasticity in Schizophrenia

Schizophrenia Disorders
University of Maryland, Baltimore36 enrolled2 locationsNCT06641297
Recruiting
Not Applicable

Investigating the Effect of Diroximel Fumarate on Glutathione in Schizophrenia

Schizophrenia Disorders
King's College London30 enrolled3 locationsNCT06957808
Recruiting
Phase 2

Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder

SchizophreniaAlcoholismSchizophrenia Disorders+5 more
Anders Fink-Jensen, MD, DMSci108 enrolled2 locationsNCT06939088
Recruiting
Not Applicable

Inter-Brain Synchrony in Schizophrenia

Schizophrenia Disorder
University of California, Los Angeles100 enrolled1 locationNCT07177261
Recruiting
Not Applicable

Randomized Clinical Trial of iTEST: A Blended Intervention Targeting Introspective Accuracy

Schizophrenia DisordersSchizoaffective DisorderPsychotic Disorder
University of California, San Diego201 enrolled3 locationsNCT07098169
Recruiting

KetoBrain: Brain Energy Metabolism in Schizophrenia

Schizophrenia Disorder
Ole Köhler-Forsberg34 enrolled1 locationNCT07309172
Recruiting
Not Applicable

Visual Perception in Schizophrenia

Schizophrenia DisordersBipolar DisorderSchizo Affective Disorder
University of Rochester84 enrolled1 locationNCT06911931
Recruiting

Creating a Global Research Database That Connects Genetic Information and Long-term Health Data to Improve Personalized Treatment for People With Serious Mental Illness

DementiaSchizophrenia DisordersBipolar Disorder (BD)+1 more
Akrivia Health50,000 enrolled1 locationNCT06641726